Top considerations for participating in an eczema clinical trial
Clinical trials are essential to advancing eczema treatment innovation. If you’re thinking about participating, there are many factors to consider, including the potential benefits and risks. Clinical trials and treatment advancements wouldn’t be possible without patient participation. We asked ESC Ambassadors who have taken part in clinical trials to share their insights.
Top clinical trial participation considerations:
- Access to new treatments – Trying new medications when other treatments haven’t worked
- Personalized medical care – Being supported by a dedicated clinical team to closely monitor your eczema
- Contributing to eczema drug advancements – Being part of a drug that can potentially improve patient lives
- Medication side effects – Understanding that you may experience side effects and understanding the potential risks
- Travel – How far away is the study? Is there free parking? Is the building accessible?
- Time commitment – What is the length of the trial? How long are appointments? What time of day are the appointments?
- Compensation – What costs are covered? How and when to submit expense claims, and when to expect payment?
- Placebo – How you might feel if you’re placed in the placebo group?
“I was so inspired to participate in a clinical trial and felt like I was really helping make a difference for others living with eczema.”
More on clinical trials
Clinical trials are crucial in advancing the care of people living with eczema. For more information about the clinical trial process, explore our Clinical Trials information page, a dermatologist’s blog “Atopic Dermatitis Clinical Trials: What You Need to Know,” and our Clinical Trial process video.
Want to become an ESC Ambassador? Share your story or perspective to support our community? Email us today.
If you or your child is struggling with eczema and needs urgent care, go to your nearest emergency department. If you need support, email ESC at info@eczemahelp.ca or connect with us through our social media channels.
May 2026
